NAPROXEN SODIUM (NAPROXEN SODIUM) — FDA Approval ANDA202807 (CATALENT)
NAPROXEN SODIUM (NAPROXEN SODIUM) — FDA Approval ANDA202807 (CATALENT) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NAPROXEN SODIUM; Active ingredients: NAPROXEN SODIUM; Application number: ANDA202807.
| Brand name | NAPROXEN SODIUM |
|---|---|
| Active ingredients | NAPROXEN SODIUM |
| Application number | ANDA202807 |
| Sponsor | CATALENT |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Over-the-counter |
| Products in application | 1 |
| First approval date | 20190104 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →